
    
      The improvement in blood vessel function and stiffness will be determined over a 10 week
      period. Subjects will be randomly assigned to either placebo (0 mg/day), low dose (80 mg/day)
      or high dose (160 mg/day) sodium nitrite. Main outcome measures will be performed at baseline
      and week 10.
    
  